Either compare revenue with revenue, or TCV with TCV...
Mixing them on the same line makes no sense, apart from giving the illusion there's exponential growth.
Also "growth" is largely all via acquisitions, would like to see figures on each segments (product) growth.
- Forums
- ASX - By Stock
- VR1
- General Company Chat
General Company Chat, page-2281
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VR1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.9¢ |
Change
0.002(7.41%) |
Mkt cap ! $38.47M |
Open | High | Low | Value | Volume |
3.0¢ | 3.2¢ | 2.9¢ | $437.2K | 14.25M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1430263 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 640246 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1430263 | 0.029 |
4 | 484856 | 0.028 |
3 | 228555 | 0.027 |
1 | 769230 | 0.026 |
6 | 2930000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 581465 | 4 |
0.033 | 946232 | 11 |
0.034 | 1971173 | 6 |
0.035 | 3045077 | 9 |
0.036 | 616130 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
VR1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online